The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate

Journal of General Virology

Volumn 86, Issue 1, 2005, Pages 75-84

  Vanladschoot, Peter ^a   Van Houtte, Freya ^a   Serruys, Benedikte ^a   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORE PROTEIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN LYASE; IMMUNOGLOBULIN; PROTAMINE; RIBONUCLEASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL LINE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS NUCLEOCAPSID;

ANIMALS; ARGININE; CELL LINE; CELL LINE, TRANSFORMED; CELL MEMBRANE; GLYCOSAMINOGLYCANS; HEPARIN LYASE; HEPARITIN SULFATE; HEPATITIS B CORE ANTIGENS; HUMANS; NUCLEOCAPSID PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RIBONUCLEASES;

HEPATITIS B VIRUS; MIRIDAE;

EID: 11444263138     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80580-0     Document Type: Article

References (42)

1. Cao, T., Lazdina, U., Desombere, I., Vanlandschoot, P., Milich, D. R., Sallberg, M. & Leroux-Roels, G. (2001). Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies in a human PBL-NOD/SCID mouse model. J Virol 75, 6359-6366.
2. Clasper, S., Vekemans, S., Fiore, M., Plebanski, M., Wordsworth, P., David, G. & Jackson, D. G. (1999). Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem 274, 24113-24123.
3. Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R. & Ballmer-Hofer, K. (2003). Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278, 35109-35114.
4. Fehr, T., Skratina, D., Pumpens, P. & Zinkernagel, R. M. (1998). T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant particles. Proc Natl Acad Sci U S A 95, 9477-9481.
5. Freissler, E., Meyer auf der Heyde, A., David, G., Meyer, T. F. & Dehio, C. (2000). Syndecan-1 and syndecan-4 can mediate the invasion of OpaHSPG-expressing Neisseria gonorrhoeae into epithelial cells. Cell Microbiol 2, 69-82.
6. Fuki, I. V., Meyer, M. E. & Williams, K. J. (2000). Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochem J 351, 607-612.
7. Futaki, S. (2002). Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 245, 1-7.
8. Gallina, A., Bonelli, F., Zentilin, L., Rindi, G., Muttini, M. & Milanesi, G. (1989). A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol 63, 4645-4652.
9. Geisberger, R., Crameri, R. & Achatz, G. (2003). Models of signal transduction through the B-cell antigen receptor. Immunology 110, 401-410.
10. Green, I., Christison, R., Voyce, C. J., Bundell, K. R. & Lindsay, M. A. (2003). Protein transduction domains: are they delivering? Trends Pharmacol Sci 24, 213-215.
11. Iozzo, R. V. (2001). Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108 165-167.
12. Jack, R. S., Grunwald, U., Stelter, F., Workalemahu, G. & Schütt, C. (1995). Both membrane-bound and soluble forms of CD14 bind to Gram-negative bacteria. Eur J Immunol 25, 1436-1441.
13. Klein, G., Giovanella, B., Westman, A., Stehlin, J. S. & Mumford, D. (1975). An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5, 319-334.
14. Lazdina, U., Cao, T., Steinberg, J., Alheim, M., Pumpens, P., Peterson, D. L., Milich, D. R., Leroux-Roels, G. & Sallberg, M. (2001). Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol 75, 6367-6374.
15. Lazdina, U., Alheim, M., Nystrom, J. & 7 other authors (2003). Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol 84, 139-146.
16. Manakil, J. F., Sugerman, P. B., Li, H., Seymour, G. J. & Bartold, P. M. (2001). Cell-surface proteoglycan expression by lymphocytes from peripheral blood and gingiva in health and periodontal disease. J Dent Res 80, 1704-1710.
17. Milich, D. R. & McLachlan, A. (1986). The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234, 1398-1404.
18. Milich, D. R., Chen, M., Schodel, F., Peterson, D. L., Jones, J. E. & Hughes, J. L. (1997a). Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 94, 14648-14653.
19. Milich, D. R., Schodel, F., Hughes, J. L., Jones, J. E. & Peterson, D. L. (1997b). The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 71, 2192-2201.
20. Pumpens, P. & Grens, E. (1999). Hepatitis B core particles as a universal display model: a structure-function basis for development. FEBS Lett 442, 1-6.
21. Rabe, B., Vlachou, A., Pante, N., Helenius, A. & Kann, M. (2003). Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 100, 9849-9854.
22. Riedl, P., Stober, D., Oehninger, C., Melber, K., Reimann, R. & Schirmbeck R. (2002). Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J Immunol 168, 4951-4959.
23. Sale, J. E. & Neuberger, M. S. (1998). TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9, 859-869.
24. Saphire, A. C., Bobardt, M. D., Zhang, Z., David, G. & Gallay, P. A. (2001). Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 75 9187-9200.
25. Seeger, C. & Mason, W. S. (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51-68.
26. Simons, M. & Horowitz, A. (2001). Syndecan-4-mediated signalling. Cell Signal 13, 855-862.
27. Steinfeld, R., Van den Berghe, H. & David, G. (1996). Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133, 405-416.
28. Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A. & Bachmann, M. F. (2004). Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 172 1777-1785.
29. Tkachenko, E., Lutgens, E., Stan, R. V. & Simons, M. (2004). Fibroblast growth factor 2 endocytosis in endothelial cells proceeds via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J Cell Sci 117, 3189-3199.
30. Turnbull, J., Powell, A. & Guimond, S. (2001). Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11, 75-82.
31. Tyagi, M., Rusnati, M., Presta, M. & Giacca, M. (2001). Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276, 3254-3261.
32. Valentine, M. A. & Licciardi, K. A. (1992). Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur J Immunol 22, 3141-3148.
33. Van der Voort, R., Keehnen, R. M. J., Beuling, E. A., Spaargaren, M. & Pals, S. T. (2000). Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. J Exp Med 192, 1115-1124.
34. Vanlandschoot, P., Cao, T. & Leroux-Roels, G. (2003). The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 60, 67-74.
35. Watts, N. R., Conway, J. F., Cheng, N., Stahl, S. J., Belnap, D. M., Steven, A. C. & Wingfield, P. T. (2002). The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 21, 876-884.
36. Wingfield, P. T., Stahl, S. J., Williams, R. W. & Steven, A. C. (1995). Hepatitis core antigen produced in Escherichia coli subunit composition, conformational analysis and in vitro capsid assembly. Biochemistry 34, 4919-4932.
37. Wynne, S. A., Crowther, R. A. & Leslie, A. G. (1999). The crystal structure of the human hepatitis B virus capsid. Mol Cell 3, 771-780.
38. Yamashita, Y., Oritani, K., Miyoshi, E. K., Wall, R., Bernfield, M. & Kincade, P. W. (1999). Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J Immunol 162, 5940-5948.
39. Zhang, W., Bardwell, P. D., Woo, C. J., Poltoratsky, V., Scharff, M. D. & Martin, A. (2001a). Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol 13, 1175-1184.
40. Zhang, Z., Coomans, C. & David, G. (2001b). Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling. Evidence in support of the "cooperative end structures" model. J Biol Chem 276, 41921-41929.
41. Zimmermann, P. & David, G. (1999). The syndecans, tuners of transmembrane signaling. FASEB J 113 (Suppl.), S91-S100.
42. Zlotnick, A., Cheng, N., Stahl, S. J., Conway, J. F., Steven, A. C. & Wingfield, P. T. (1997). Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci U S A 94, 9556-9561.